Treatment with human parathyroid hormone (1-34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys (Macaca fascicularis)
- 13 February 2001
- Vol. 28 (2) , 150-159
- https://doi.org/10.1016/s8756-3282(00)00430-0
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Daily Treatment with Human Recombinant Parathyroid Hormone-(1-34), LY333334, for 1 Year Increases Bone Mass in Ovariectomized MonkeysJournal of Clinical Endocrinology & Metabolism, 1999
- Anabolic Effects of Human Biosynthetic Parathyroid Hormone Fragment (1–34), LY333334, on Remodeling and Mechanical Properties of Cortical Bone in RabbitsJournal of Bone and Mineral Research, 1999
- Is Parathyroid Hormone a Therapeutic Option for Osteoporosis? A Review of the Clinical EvidenceCalcified Tissue International, 1998
- Effects of intermittent hPTH(1–34) alone and in combination with 1,25(OH)2d3 or risedronate on endosteal bone remodeling in canine cancellous and cortical boneJournal of Bone and Mineral Research, 1996
- Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized ratsBone, 1995
- Anabolic Actions of Parathyroid Hormone on Bone*Endocrine Reviews, 1993
- Treatment of osteoporosis with parathyroid peptide (hPTH 1–34) and oestrogen: increase in volumetric density of iliac cancellous bone may depend on reduced trabecular spacing as well as increased thickness of packets of newly formed boneClinical Endocrinology, 1992
- Bone hypertrophy and trabecular generation in Paget's disease and in fluoride-treated osteoporosisBone and Mineral, 1992
- Loss of the anabolic effect of parathyroid hormone on bone after discontinuation of hormone in ratsBone, 1989
- Histogenesis of hyperosteoidosis in 1,25(OH)2D3-treated rats fed high levels of dietary calciumBone, 1985